Document is current
Any future updates will be listed below
-
Authors
Hertoghs, Nina
Tang, Chan
van Paassen, Vitalija
Jongeneelen, Mandy
Tolboom, Jeroen
Yieh, Lynn https://orcid.org/0009-0003-6044-6696
Wang, Miao
Kaszas, Krisztian https://orcid.org/0000-0002-8643-9262
McLean, Chelsea https://orcid.org/0000-0002-3548-3482
van den Berg, Sara
Lowson, David
Hu, Weihong
Aguilar, Zuleima https://orcid.org/0009-0001-2927-0130
Hendriks, Jenny
Kuipers, Harmjan https://orcid.org/0000-0003-1317-394X
Kulke, Sarah
Sadoff, Jerald
Brandenburg, Boerries
Zahn, Roland https://orcid.org/0000-0003-2822-6231
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | Biomedical Advanced Research and Development Authority (HSO100201700018C)
Johnson and Johnson (N/A)
- License Information
-
More Information
Article History
Received: 19 December 2025
Accepted: 24 February 2026
First Online: 13 April 2026
Competing interests
: All authors are or were employees of Johnson & Johnson and may hold Johnson & Johnson stock.B.B. and M.J. are named inventors on a patent granted for the HA antigen (US11905314B2).
